THE ROLE OF LAMININ 5 IN DIABETIC ULCER HEALING
层粘连蛋白 5 在糖尿病溃疡愈合中的作用
基本信息
- 批准号:6789928
- 负责人:
- 金额:$ 49.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-09-30 至 2006-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (adapted from the application)
One of the stated goals of Healthy People 2000 is to reduce the incidence of
lower extremity amputation in diabetic patients from the 1988 baseline rate of
8.2/1000 to a target incidence of 4.9/1000 in the year 2000. Despite efforts
directed at prevention, the rate of amputation has continued to rise in
patients with DM. A better understanding of the pathogenesis of diabetic ulcers
and novel treatment strategies are required to reverse the rising trend in the
rate of amputation. The goal of this application is to use new molecular
technologies to enhance healing of diabetic ulcers by increasing the migration
of cells (keratinocytes) at the ulcer margin. The laminin 5 (Lam 5)
cell-signaling pathway is the focus of this investigation. An interdisciplinary
team will conduct the proposed experiments in patients and mice with DM. This
application will test three general HYPOTHESES: 1. The principle deficit in
closure of diabetic ulcers is failure of keratinocyte migration despite marked
keratinocyte proliferation at the ulcer margin. 2. Lam 5 mediated signaling,
essential for keratinocyte migration, is impaired in diabetes mellitus. 3.
Clarification of Lam 5 cellsignaling pathways will lead to novel approaches to
stimulate keratinocyte migration and speed healing of diabetic ulcers. In order
to test these hypotheses we will carry out the following Specific Aims:
Specific Aim 1. Characterize chronic ulcers from patients with diabetes and
acute wounds from diabetic and normal human subjects/mice regarding Lam 5
isoforms and Lam 5 mRNA, the Lam 5 associated integrins alpha6-beta4
alpha3-beta1 and the proliferation marker Ki67. Specific Aim 2. Evaluate
functions for Lam 5 sub-domains as well as design and produce recombinant
isoforms of Lam 5. Specific Aim 3. Evaluate mechanisms by which keratinocytes
regulate synthesis and deposition of Lam 5, and evaluate the role of Lam 5 in
the migration of normal and diabetic cells. Specific Aim 4. Assess the effects
of application of recombinant Lam 5 isoforms to the wounds of db/db diabetic
mice and develop bioniaterials that elicit a maximal increase in healing rate.
描述(改编自应用程序)
项目成果
期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Epidermal and dermal integration into sphere-templated porous poly(2-hydroxyethyl methacrylate) implants in mice.
- DOI:10.1002/jbm.a.32798
- 发表时间:2010-09-15
- 期刊:
- 影响因子:4.9
- 作者:Fukano, Y.;Usui, M. L.;Underwood, R. A.;Isenhath, S.;Marshall, A. J.;Hauch, K. D.;Ratner, B. D.;Olerud, J. E.;Fleckman, P.
- 通讯作者:Fleckman, P.
Ultrastructural localization of integrin subunits beta4 and alpha3 within the migrating epithelial tongue of in vivo human wounds.
整合素亚基β4和α3在体内人类伤口迁移上皮舌内的超微结构定位。
- DOI:10.1369/jhc.2008.952176
- 发表时间:2009
- 期刊:
- 影响因子:0
- 作者:Underwood,RobertA;Carter,WilliamG;Usui,MarciaL;Olerud,JohnE
- 通讯作者:Olerud,JohnE
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN Everett OLERUD其他文献
JOHN Everett OLERUD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN Everett OLERUD', 18)}}的其他基金
Percutaneous Devices Permitting Skin Cell Attachment
允许皮肤细胞附着的经皮装置
- 批准号:
7093475 - 财政年份:2005
- 资助金额:
$ 49.75万 - 项目类别:
Percutaneous Devices Permitting Skin Cell Attachment
允许皮肤细胞附着的经皮装置
- 批准号:
7415026 - 财政年份:2005
- 资助金额:
$ 49.75万 - 项目类别:
Percutaneous Devices Permitting Skin Cell Attachment
允许皮肤细胞附着的经皮装置
- 批准号:
6987044 - 财政年份:2005
- 资助金额:
$ 49.75万 - 项目类别:
Percutaneous Devices Permitting Skin Cell Attachment
允许皮肤细胞附着的经皮装置
- 批准号:
7214683 - 财政年份:2005
- 资助金额:
$ 49.75万 - 项目类别:
Percutaneous Devices Permitting Skin Cell Attachment-Inhibiting Biofilm Formation
允许皮肤细胞附着抑制生物膜形成的经皮装置
- 批准号:
7192310 - 财政年份:2004
- 资助金额:
$ 49.75万 - 项目类别:
THE ROLE OF LAMININ 5 IN DIABETIC ULCER HEALING
层粘连蛋白 5 在糖尿病溃疡愈合中的作用
- 批准号:
6524410 - 财政年份:2000
- 资助金额:
$ 49.75万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 49.75万 - 项目类别:
Research Grant
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 49.75万 - 项目类别:
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 49.75万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 49.75万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 49.75万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 49.75万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 49.75万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 49.75万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 49.75万 - 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
- 批准号:
10828252 - 财政年份:2023
- 资助金额:
$ 49.75万 - 项目类别:














{{item.name}}会员




